This DOLF study will investigate the safety and effectiveness of IDA treatment in persons with onchocerciasis when it is administered after pre-treatment with ivermectin to clear or greatly reduce microfilariae from the skin and eyes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rates of Severe Adverse Events (SAEs) Across Study Arms
Timeframe: Within 7 days following end of treatment
Percentage of Worms Killed Across Study Arms
Timeframe: 18 months following treatment.
Percentage of Worms Sterilized Across Study Arms
Timeframe: 18 months following treatment.